Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

70.46
-0.1400-0.20%
Pre-market: 73.352.89+4.10%07:49 EDT
Volume:7.50M
Turnover:530.59M
Market Cap:41.27B
PE:10.11
High:72.75
Open:71.97
Low:69.84
Close:70.60
Loading ...

Shield AI and L3Harris Team for Breakthrough in Autonomy

PR Newswire
·
27 Feb

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
26 Feb

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Business Wire
·
25 Feb

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
20 Feb

Top Research Reports for Meta Platforms, BlackRock & Palo Alto

Zacks
·
20 Feb

AV Unveils JUMP 20-X: Revolutionizing Autonomous Maritime Operations with Unmatched Precision and Versatility

Business Wire
·
17 Feb

The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings

Simply Wall St.
·
16 Feb

Edwards Lifesciences: Strong Performance Amid Modest Future Growth Expectations and Operational Challenges

TIPRANKS
·
15 Feb

Edwards Lifesciences Director Makes a Significant Stock Sale!

TIPRANKS
·
15 Feb

Director Cashes In on Edwards Lifesciences Stock in Major Sale

TIPRANKS
·
14 Feb

Edwards Lifesciences Is Maintained at Overweight by Barclays

Dow Jones
·
13 Feb

Edwards Lifesciences: Promising Growth with Strong Performance in TMTT and TAVR Segments Justifies Buy Rating

TIPRANKS
·
13 Feb

Edwards Lifesciences price target raised to $71 from $66 at Canaccord

TIPRANKS
·
13 Feb

Edwards Lifesciences Corp : Canaccord Genuity Raises Target Price to $71 From $68

THOMSON REUTERS
·
13 Feb

Edwards Lifesciences: Strong Q4 Performance Overshadowed by Unchanged 2025 Outlook and Capacity Constraints

TIPRANKS
·
13 Feb

Edwards Lifesciences’ Earnings Call Highlights Strong Growth

TIPRANKS
·
13 Feb

Evercore ISI Reaffirms Their Hold Rating on Edwards Lifesciences (EW)

TIPRANKS
·
13 Feb

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Benzinga
·
13 Feb

Edwards Lifesciences Price Target Maintained With a $85.00/Share by RBC Capital

Dow Jones
·
13 Feb

Q4 2024 Edwards Lifesciences Corp Earnings Call

Thomson Reuters StreetEvents
·
12 Feb